COL4A2 is likely a potential biomarker in esophageal cancer (Warnecke-Eberz et al., 2016), lung cancer (Ilhan-Mutlu et al., 2016), and breast cancer (Huan et al., 2014). Here, COL4A2 is linked to lung carcinoma.